NIH-funded research R01 grant

Serotonin-based Treatments for Cerebral Palsy in Young Children

Official title: Serotonin Based Therapeutics in Cerebral Palsy

Funded at University of Rhode Island · NIH-11369926 · Data updated 2026-11-12

Aimed at helping kids with cerebral palsy, this project tests whether blocking serotonin signals in developing spinal circuits can reduce muscle stiffness and improve movement.

More Cerebral Palsy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Rhode Island
NIH-funded
Lab location1 site (Kingston, United States)
Project startAugust 8, 2023
Project endJuly 31, 2028
Funding year2026
Award (this year)$599,106
NIH project number5R01NS132728-04
Project IDNIH-11369926 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children with spastic cerebral palsy or related motor dysfunction stemming from early developmental injury, who could benefit from future therapies targeting serotonin pathways.

Less likely to help

Children with CP due to non-serotonergic mechanisms or those outside the developmental window for planned interventions may see limited or no benefit.

What this research studies

This research focuses on young children with cerebral palsy and investigates how blocking specific serotonin receptors during development might normalize motor nerve activity. Using a animal model of CP that mimics human motor problems, the team will study how 5-HT antagonists affect motor neuron behavior and muscle control. The goal is to see if these treatments can lessen hypertonia, weakness, and exaggerated reflexes by stabilizing spinal circuitry during a critical growth period. Results could guide future therapies that improve daily movement and quality of life for affected children.

Why it matters

Potential benefit: If successful, the approach could lead to new therapies that reduce stiffness and improve motor function in children with CP.

How similar studies have gone: Preclinical models have shown that altering serotonin signaling can modify motor neuron activity and mitigate motor deficits in CP-like conditions.

Where this research is happening

  • University of Rhode Island
    Kingston, United States
    Active

Researchers

  • Principal investigator: Quinlan, Katharina Ann — University of Rhode Island
  • Study coordinator: Quinlan, Katharina Ann

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.